Volume 5, 2022

Jason Cottrell, Mitchell Silver Abstract Historically, anticoagulation has been the primary treatment for acute lower extremity deep venous thrombosis (DVT) with or without thrombolysis. Despite large amounts of clinical research data supporting an ‘open vein hypothesis’, which favours early thrombus removal, clinicians have been hesitant to take this option due to a historically high risk

Rosemary Denning Ho, Vivek Shrivastava, Amir Mokhtari, Raghuram Lakshminarayan Abstract Renal injuries are the most common urinary tract injury secondary to external abdominal trauma. They are caused by blunt, penetrating and iatrogenic mechanisms. Despite the high number of blunt renal injuries, little evidence is available to guide management, especially with the evolution of embolisation as

Harold J Welch Abstract The anterior accessory saphenous vein (AASV) is a common source of primary and recurrent lower extremity varicose veins. Reflux in the AASV can occur independently or simultaneously with great saphenous vein (GSV) reflux. A number of published reports describe recommendations and treatment of symptomatic refluxing AASVs, but descriptions of combined treatment

Mustafa Abbas, Trevor Cleveland Abstract Carotid interventions, carotid endarterectomy and carotid artery stenting (CAS) have proven to be effective treatments for the prevention of ischaemic stroke in recently symptomatic patients. Most studies were conducted before the development of strict statin guidance and the systematic use of antiplatelet drugs. The advances in medical treatments have raised

Suresh Vedantham, Sameer Parpia, Susan R Kahn Abstract Patients with post-thrombotic syndrome (PTS) and iliac vein obstruction have lower extremity symptoms, activity limitation and impairment of health-related quality of life. Preliminary studies suggest that iliac vein stent placement, which eliminates venous outflow obstruction, may reduce the clinical severity of PTS. However, stent placement is associated

Maria Joh,Kush R Desai Abstract Non-thrombotic iliac vein lesions (NIVLs) refer to iliac vein lumen stenosis, usually secondary to extrinsic compression, without associated thrombosis. Clinical presentation varies; patients may be asymptomatic, have symptoms of lower extremity venous hypertension, or in women, may be associated with chronic pelvic pain. Given the significant variability in symptomatology, thorough

Adham Abou Ali, Othman A Malak, Karim Salem, George Alkhoury, Natalie Sridharan, Rabih A Chaer, Efthymios D Avgerinos Abstract Extension of an iliofemoral thrombosis into the inferior vena cava (IVC), or from the IVC descending into the iliofemoral segments, can confer significant morbidity and mortality. Interventional management of acute deep vein thrombosis (DVT) has been

Nolan Mann, Hosam El Sayed, Jean Panneton Abstract Endovascular treatment has become an accepted method in the treatment of aortoiliac occlusive disease. Bare metal stents have been used in the treatment of aortoiliac disease since the early 1990s. More recently, the use of covered stent grafts in the aortoiliac segment has shown clinical benefit in

Gergana Todorova Taneva, Jaime Muñoz Castellanos, Konstantinos P Donas Keywords: Subclavian vein thrombosis, Paget–Schroetter syndrome, pharmacomechanical thrombectomy, anticoagulation therapy, deep vein thrombosis treatment, thoracic outlet syndrome Disclosure:GTT and KPD are on the Vascular & Endovascular Review editorial board; this did not influence acceptance. JMC has no conflicts of interest to declare. Received: 02 November 2021: Accepted: 06 December 2021: Published